Behavioral effects of δ-opioid receptor agonists: Potential antidepressants?

Japanese Journal of Pharmacology

Volumn 90, Issue 1, 2002, Pages 1-6

  Broom, Daniel C ^a   Jutkiewicz, Emily M ^a   Rice, Kenner C ^a   Traynor, John R ^a   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Depression; Enkephalin; Forced swim assay; Opioid agonist

Indexed keywords

3 [2 BENZYL 3 (PROPIONYLTHIO)PROPIONAMIDO] 5 METHYLBENZOIC ACID; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ANTIDEPRESSANT AGENT; BENZAMIDE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BU 48; BUPRENORPHINE; CLOMIPRAMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DESIPRAMINE; ENKEPHALIN; ENKEPHALINASE INHIBITOR; FLUOXETINE; IMIPRAMINE; LEUCINE ENKEPHALIN[2 DEXTRO O TERT BUTYLSERINE 6 O TERT BUTYLTHREONINE]; MIDAZOLAM; N [2 BENZYL 3 [(HYDROXYAMINO)CARBONYL]PROPIONYL]PHENYLALANINE; N [3 [(2 AMINO 4 METHYLTHIO)BUTYLDITHIO] 2 BENZYLPROPIONYL]PHENYLALANINE BENZYL ESTER; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALTREXONE; NALTRINDOLE; OPIATE ANTAGONIST; OPIATE PEPTIDE; PD 101; PENTETRAZOLE; RB 38B; SHORT ACTING DRUG; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTICONVULSANT ACTIVITY; ANTINOCICEPTION; BEHAVIOR; DEPRESSION; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG TOLERANCE; ELECTROCONVULSIVE THERAPY; ENZYME INHIBITION; FORCED SWIMMING TEST; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN DEGRADATION; RAT; REVIEW; SEIZURE; STRUCTURE ANALYSIS;

EID: 0036749063     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.90.1     Document Type: Review

References (35)

1. Porreca F and Burks TF: Supraspinal opioid receptors in antinociception. In Handbook of Experimental Pharmacology, Edited by Herz A, Akil H and Simon EJ, Vol 104/II, pp 21-51, Springer-Verlag, Berlin (1993)
2. Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, Cowell SM, Slate CA, Ehlert FJ, Roeske WR and Yamamura HI: The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51, 503-532 (1999)
3. Wild KD, McCormick J, Bilsky EJ, Vanderah T, McNutt RW, Chang K-J and Porreca F: Antinociceptive actions of BW373U86 in the mouse. J Pharmacol Exp Ther 267, 858-865 (1993)
4. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC and Porreca F: SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273, 359-366 (1995)
5. Negus SS, Butelman ER, Chang K-J, DeCosta B, Winger G and Woods JH: Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270, 1025-1034 (1994)
6. Tortella FC: Endogenous opioid peptides and epilepsy: quieting the seizing brain? Trends Pharmacol Sci 9, 366-372 (1988)
7. Frenk H: Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res Rev 6, 197-210 (1983)
8. Gildbert PE and Martin WR: Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice. J Pharmacol Exp Ther 192, 538-541 (1975)
9. Haffmans J and Dzoljic MR: Differential epileptogenic potentials of selective mu and delta opiate agonists. J Neural Transm 57, 1-11 (1983)
10. Tortella FC, Robles L, Mosberg HI and Holaday JW: Electroencephalographic assessment of the role of δ receptors in opioid peptide-induced seizures. Neuropeptides 5, 213-216 (1984)
11. Haffmans J and Dzoljic MR: Effects of delta opioid antagonists of enkephalin-induced seizures. Pharmacology 34, 61-65 (1987)
12. De Sarro GB, Marra R, Spagnolo C and Nistico G: Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats. Funct Neurol 7, 235-238 (1992)
13. Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang K-J, De Costa BR, Mosberg HI and Woods JH: Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 267, 888-895 (1993)
14. Hong EJ, Rice KC, Calderon SN, Woods JH and Traynor JR: Convulsive behavior of nonpeptide δ-opioid ligands: comparison of SNC80 and BW373U86 in mice. Analgesia 3, 269-276 (1998)
15. Broom DC, Guo L, Coo A, Husbands S, Lewis JW, Woods JH and Traynor JR: BU48: A novel buprenorphine analogue that exhibits delta-opioid mediated convulsions but not delta-opioid mediated antinociception in mice. J Pharmacol Exp Ther 294, 1195-1200 (2000)
16. Dykstra LA, Schoenbaum GM, Yarbrough J, McNutt R and Chang K-J: A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. J Pharmacol Exp Ther 267, 875-882 (1993)
17. Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC and Woods JH: Convulsant activity of a nonpeptidic δ-opioid receptor agonist is not required for its antidepressant-like activity in Sprague-Dawley rats. Psychopharmacology (Berl) (in press)
18. Baraldi M, Poggioli R, Santi M, Vergoni AV and Bertolini A: Antidepressants and opiate interactions: pharmacological and biochemical evidences. Pharmacol Res Commun 15, 843-857 (1983)
19. Martin P, Soubrie P and Simon P: Noradrenergic and opioid mediation of tricyclic-induced reversal of escape deficits caused by inescapable shock pretreatment in rats. Psychopharmacology (Berl) 90, 90-94 (1986)
20. de Gandarias JM, Casis O, Varona A, Gallego M, Irazusta J and Casis L: Interactions mechanisms of imipramine and desipramine with enkephalin-degrading aminopeptidases in vitro. Life Sci 61, PL321-PL326 (1997)
21. Carmen de Felipe M, De Ceballos ML, Gil C and Fuentes JA: Chronic antidepressant treatment increases enkephalin levels in N. accumbens and striatum of the rat. Eur J Pharmacol 112, 119-122 (1985)
22. Hong JS, Gillin JC, Yang H-YT and Costa E: Repeated electroconvulsive shocks and the brain content of endorphins. Brain Res 177, 273-278, (1979)
23. 1 receptor stimulation. Eur J Pharmacol 216, 157-166 (1992)
24. Tejedor-Real P, Mico JA, Maldonado R, Roques BP and Gibert-Rahola J: Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. Biol Psychiatry 34, 100-107 (1993)
25. Tejedor-Real P, Mico JA, Maldonado R, Roques BP and Gibert-Rahola J: Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 52, 145-152 (1995)
26. Kita A, Imano K, Seto Y, Yakuo I, Deguchi T and Nakamura H: Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats. Jpn J Pharmacol 75, 337-346 (1997)
27. Tejedor-Real P, Mico JA, Smadja C, Maldonado R, Roques BP and Gibert-Rahola J: Involvement of δ-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur J Pharmacol 354, 1-7 (1998)
28. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HWD, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R and Kieffer BL: Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nature Genetics 25, 195-200 (2000)
29. Kline NS, Li CH, Lehmann HE, Lajtha A, Laski E and Copper T: β-Endorphin-induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry 34, 1111-1113 (1977)
30. Emrich HM, Hollt V, Kissling W, Fischler M, Laspe H, Heinemann H, von Zerssen D and Herz A: β-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders. Pharmakopsychiatry 12, 269-276 (1979)
31. Inturrisi CE, Alexopoulos G, Lipman R, Foley K and Rossier J: β-Endorphin immunoreactivity in the plasma of psychiatric patients receiving electroconvulsive treatment. Ann NY Acad Sci 398, 413-423 (1982)
32. Hollister LE, Johnson K, Boukhabza D and Gillespie HK: Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alc Depend 8, 37-41 (1981)
33. Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC and Woods JH: Nonpeptidic δ-opioid receptor agonists redue immobility in the forced swim assay in rats. Neuropsychopharmacology 26, 744-755 (2002)
34. Detke MJ, Rickels M and Lucki I: Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121, 66-72 (1995)
35. Reneric J-P and Lucki I: Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 136, 190-197 (1998)